Fabio Cataldi
Chief Tech/Sci/R&D Officer bei LANDOS BIOPHARMA, INC.
Vermögen: - $ am 31.03.2024
Profil
Fabio Cataldi is currently the Chief Medical Officer & Executive Vice President at Landos Biopharma, Inc. He previously worked as the Senior Director-Gastroenterology Biotherapeutics at Pfizer Inc. from 2010 to 2015.
He also held the position of Vice President & Head-Gastroenterology at Arena Pharmaceuticals, Inc. Additionally, he served as the VP-Clinical Development in Internal Medicine at Shire Japan KK from 2015 to 2017.
Dr. Cataldi obtained a doctorate degree from the University of Campania Luigi Vanvitelli.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
LANDOS BIOPHARMA, INC.
-.--% | 31.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Fabio Cataldi
Unternehmen | Position | Beginn |
---|---|---|
LANDOS BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 05.09.2022 |
Ehemalige bekannte Positionen von Fabio Cataldi
Unternehmen | Position | Ende |
---|---|---|
Shire Japan KK
Shire Japan KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Japan KK is a Japanese pharmaceutical company that manufactures pharmaceuticals. The private company is based in Tokyo, Japan. | Corporate Officer/Principal | 01.07.2017 |
PFIZER, INC. | Corporate Officer/Principal | 01.07.2015 |
ARENA PHARMACEUTICALS | Corporate Officer/Principal | - |
Ausbildung von Fabio Cataldi
University of Campania Luigi Vanvitelli | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PFIZER, INC. | Health Technology |
LANDOS BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Shire Japan KK
Shire Japan KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Japan KK is a Japanese pharmaceutical company that manufactures pharmaceuticals. The private company is based in Tokyo, Japan. | Health Technology |